GSK Acquires Dermatology Products from Elan
Business Review Editor
Abstract
GlaxoSmithKline (GSK) Consumer Healthcare acquired five dermatology products from Elan. The products acquired and marketed are Aclovate®, Cutivate®, Temovate®, Oxistat® and Emgel®.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.